Hussain RM[Author] - Search Results

Year	Number of Results
1996	2
2001	1
2003	1
2009	2
2013	1
2014	6
2015	6
2016	7
2017	8
2018	11
2019	10
2020	10
2021	5
2022	6
2023	0

1

Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration.

Hussain RM, Shaukat BA, Ciulla LM, Berrocal AM, Sridhar J. Hussain RM, et al. Drug Des Devel Ther. 2021 Jun 21;15:2653-2665. doi: 10.2147/DDDT.S295223. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34188445 Free PMC article. Review.

2

Innovative therapies for neovascular age-related macular degeneration.

Al-Khersan H, Hussain RM, Ciulla TA, Dugel PU. Al-Khersan H, et al. Among authors: hussain rm. Expert Opin Pharmacother. 2019 Oct;20(15):1879-1891. doi: 10.1080/14656566.2019.1636031. Epub 2019 Jul 12. Expert Opin Pharmacother. 2019. PMID: 31298960 Review.

3

Complement inhibition as a therapeutic strategy in retinal disorders.

Kassa E, Ciulla TA, Hussain RM, Dugel PU. Kassa E, et al. Among authors: hussain rm. Expert Opin Biol Ther. 2019 Apr;19(4):335-342. doi: 10.1080/14712598.2019.1575358. Epub 2019 Feb 11. Expert Opin Biol Ther. 2019. PMID: 30686077 Review.

4

Tie-2/Angiopoietin pathway modulation as a therapeutic strategy for retinal disease.

Hussain RM, Neiweem AE, Kansara V, Harris A, Ciulla TA. Hussain RM, et al. Expert Opin Investig Drugs. 2019 Oct;28(10):861-869. doi: 10.1080/13543784.2019.1667333. Epub 2019 Sep 26. Expert Opin Investig Drugs. 2019. PMID: 31513439 Review.

5

Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy.

Hussain RM, Ciulla TA. Hussain RM, et al. Expert Opin Biol Ther. 2016;16(3):365-74. doi: 10.1517/14712598.2016.1131265. Epub 2016 Jan 12. Expert Opin Biol Ther. 2016. PMID: 26674182 Free article. Review.

6

Purtscher's Retinopathy.

Hussain RM, Yung CW. Hussain RM, et al. Ophthalmology. 2016 Aug;123(8):1666. doi: 10.1016/j.ophtha.2016.04.046. Ophthalmology. 2016. PMID: 27450816 No abstract available.

7

Stargardt macular dystrophy and evolving therapies.

Hussain RM, Ciulla TA, Berrocal AM, Gregori NZ, Flynn HW Jr, Lam BL. Hussain RM, et al. Expert Opin Biol Ther. 2018 Oct;18(10):1049-1059. doi: 10.1080/14712598.2018.1513486. Epub 2018 Sep 10. Expert Opin Biol Ther. 2018. PMID: 30129371 Review.

8

Gene therapy for age-related macular degeneration.

Moore NA, Bracha P, Hussain RM, Morral N, Ciulla TA. Moore NA, et al. Among authors: hussain rm. Expert Opin Biol Ther. 2017 Oct;17(10):1235-1244. doi: 10.1080/14712598.2017.1356817. Epub 2017 Jul 20. Expert Opin Biol Ther. 2017. PMID: 28726562 Review.

9

Current Concepts and Emerging Gene Therapies for Inherited Retinal Diseases.

Gregori NZ, Hussain RM, Kay CN, Lam BL, Dermer H, Davis JL. Gregori NZ, et al. Among authors: hussain rm. Int Ophthalmol Clin. 2019 Winter;59(1):83-110. doi: 10.1097/IIO.0000000000000259. Int Ophthalmol Clin. 2019. PMID: 30585920 Review. No abstract available.

10

KSI-301: an investigational anti-VEGF biopolymer conjugate for retinal diseases.

Stern HD, Hussain RM. Stern HD, et al. Among authors: hussain rm. Expert Opin Investig Drugs. 2022 May;31(5):443-449. doi: 10.1080/13543784.2022.2052042. Epub 2022 Mar 16. Expert Opin Investig Drugs. 2022. PMID: 35285359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results